Skip to content

Disparities Among Liver Transplant Patients

Individual and Structural-level Determinants Associated With Disparities Among Liver Transplant Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05981196
Enrollment
100
Registered
2023-08-08
Start date
2023-11-15
Completion date
2026-10-31
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Liver DIsease

Keywords

Transplants, Transplantation, Healthcare Disparities, Minority Health, Communication

Brief summary

The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.

Detailed description

Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction. Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender). Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

\- Patients with end-stage liver, kidney, or cardiac dysfunction.

Exclusion criteria

* Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant. * Patients with potential medical exclusions for transplant.

Design outcomes

Primary

MeasureTime frameDescription
Liver transplant waiting listApproximately one yearNumber of subjects listed on the liver transplant waiting list
Organ transplantationApproximately one yearNumber of subject to receive an organ transplantation

Secondary

MeasureTime frameDescription
Graft survival at six monthsSix months post transplantTotal number of subject to have a functioning graft at six months post transplant
Graft survival at one yearOne year post transplantTotal number of subject to have a functioning graft at one year post transplant
SurvivalApproximately one year post-transplant, or until you are removed from the transplant listTotal number of subject alive

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPeter E. Frasco, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026